• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Theralase Technologies Inc (OP:TLTFF)

    0.1182 +0.0018 (+1.55%)
    Streaming Delayed Price Updated: 3:59 PM EST, Dec 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Theralase Technologies Inc

    < Previous 1 2 3 Next >
    News headline image
    Theralase(R) Closes $1.3 M Non-Brokered Private Placement
    Toronto, Ontario--(Newsfile Corp. - December 23, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage... 
    Via Newsfile
    News headline image
    Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
    Toronto, Ontario--(Newsfile Corp. - December 12, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage... 
    Via Newsfile
    News headline image
    Theralase(R) Investor Conference Call Reminder
    Toronto, Ontario--(Newsfile Corp. - November 17, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    Theralase(R) Releases 3Q2025 Financial Statements
    Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - Theralase® Technologies Inc. (TSXV:TLT) (OTCQB:TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering... 
    Via Newsfile
    News headline image
    CORRECTING AND REPLACING: Theralase(R) Demonstrates Effective Treatment of Herpes
    Via ACCESS Newswire
    News headline image
    Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug
    Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage... 
    Via Newsfile
    News headline image
    Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus
    Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical... 
    Via Newsfile
    Topics Derivatives
    News headline image
    Theralase(R) Extends Warrants
    Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage... 
    Via Newsfile
    News headline image
    Theralase(R) Releases 2Q2025 Financial Statements
    Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage... 
    Via Newsfile
    News headline image
    Theralase(R) Closes Non-Brokered Private Placement
    Toronto, Ontario--(Newsfile Corp. - July 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage... 
    Via Newsfile
    News headline image
    Theralase(R) Extends Warrants
    Toronto, Ontario--(Newsfile Corp. - June 27, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical... 
    Via Newsfile
    News headline image
    Theralase(R) Closes Non-Brokered Private Placement
    Toronto, Ontario--(Newsfile Corp. - June 17, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage... 
    Via Newsfile
    News headline image
    Theralase Completes Annual General and Special Meeting
    Toronto, Ontario--(Newsfile Corp. - June 12, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical... 
    Via Newsfile
    News headline image
    Theralase Annual General Meeting
    Toronto, Ontario--(Newsfile Corp. - June 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    Theralase(R) 1Q2025 Financial Statements
    Toronto, Ontario--(Newsfile Corp. - May 30, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025
    This Press Release removes references to preclinical data that has not yet been presented.Toronto, Ontario--(Newsfile Corp. - May 29, 2025)... 
    Via Newsfile
    News headline image
    Theralase to Present Groundbreaking Research at ASTRO 2025
    Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    Theralase Provides Corporate Update
    Toronto, Ontario--(Newsfile Corp. - May 20, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
    Toronto, Ontario--(Newsfile Corp. - May 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    Theralase Discovers New Mechanism of Action of Lead Drug
    Toronto, Ontario--(Newsfile Corp. - April 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    Theralase(R) Closes Non-Brokered Private Placement
    Toronto, Ontario--(Newsfile Corp. - April 14, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments
    Toronto, Ontario--(Newsfile Corp. - April 10, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical... 
    Via Newsfile
    News headline image
    Ruvidar Demonstrates 7 Year Complete Response
    Toronto, Ontario--(Newsfile Corp. - April 7, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical... 
    Via Newsfile
    News headline image
    Ruvidar Effective in the Treatment of Herpes
    Toronto, Ontario--(Newsfile Corp. - March 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    Theralase(R) Releases 2024 Annual Financial Statements
    Toronto, Ontario--(Newsfile Corp. - March 12, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    Theralase(R) Closes Non-Brokered Private Placement
    Toronto, Ontario--(Newsfile Corp. - March 11, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    Theralase(R) Therapy Improves Motor and Non-Motor Function in Parkinson's Patients
    Toronto, Ontario--(Newsfile Corp. - March 10, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a... 
    Via Newsfile
    News headline image
    Theralase(R) Demonstrates Efficacy of Rutherrin(R) in Destruction of Non-Hodgkin's Lymphoma
    Toronto, Ontario--(Newsfile Corp. - February 25, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical... 
    Via Newsfile
    Topics Death
    News headline image
    Theralase(R) Demonstrates Effective Treatment of Herpes
    Via ACCESS Newswire
    News headline image
    Theralase(R) Releases Latest Research on Inactivation of Herpes Simplex Viruses
    Via ACCESS Newswire
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.